• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大鼠组织中从胰腺上皮内瘤变到胰腺导管腺癌的代谢组学变化。

Metabonomic changes from pancreatic intraepithelial neoplasia to pancreatic ductal adenocarcinoma in tissues from rats.

作者信息

Wen Shi, Li Zhishui, Feng Jianghua, Bai Jianxi, Lin Xianchao, Huang Heguang

机构信息

Department of General Surgery, Fujian Medical University Union Hospital, Fuzhou, China.

Department of Electronic Science, Fujian Provincial Key Laboratory of Plasma and Magnetic Resonance, Xiamen University, Xiamen, China.

出版信息

Cancer Sci. 2016 Jun;107(6):836-45. doi: 10.1111/cas.12939. Epub 2016 May 17.

DOI:10.1111/cas.12939
PMID:27019331
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4968602/
Abstract

Pancreatic ductal adenocarcinoma (PDAC) is one of the most malignant tumors and is difficult to diagnose in the early phase. This study was aimed at obtaining the metabolic profiles and characteristic metabolites of pancreatic intraepithelial neoplasia (PanIN) and PDAC tissues from Sprague-Dawley (SD) rats to establish metabonomic methods used in the early diagnosis of PDAC. In the present study, the animal models were established by embedding 7,12-dimethylbenzanthracene (DMBA) in the pancreas of SD rats to obtain PanIN and PDAC tissues. After the preprocessing of tissues, (1) H nuclear magnetic resonance (NMR) spectroscopy combined with multivariate and univariate statistical analysis was applied to identify the potential metabolic signatures and the corresponding metabolic pathways. Pattern recognition models were successfully established and differential metabolites, including glucose, amino acids, carboxylic acids and coenzymes, were screened out. Compared with the control, the trends in the variation of several metabolites were similar in both PanIN and PDAC. Kynurenate and methionine levels were elevated in PanIN but decreased in PDAC, thus, could served as biomarkers to distinguish PanIN from PDAC. Our results suggest that NMR-based techniques combined with multivariate statistical analysis can distinguish the metabolic differences among PanIN, PDAC and normal tissues, and, therefore, present a promising approach for physiopathologic metabolism investigations and early diagnoses of PDAC.

摘要

胰腺导管腺癌(PDAC)是最恶性的肿瘤之一,早期难以诊断。本研究旨在获取来自Sprague-Dawley(SD)大鼠的胰腺上皮内瘤变(PanIN)和PDAC组织的代谢谱及特征性代谢物,以建立用于PDAC早期诊断的代谢组学方法。在本研究中,通过将7,12-二甲基苯并蒽(DMBA)植入SD大鼠胰腺来建立动物模型,以获取PanIN和PDAC组织。组织预处理后,应用(1)氢核磁共振(NMR)光谱结合多变量和单变量统计分析来识别潜在的代谢特征及相应的代谢途径。成功建立了模式识别模型,并筛选出包括葡萄糖、氨基酸、羧酸和辅酶在内的差异代谢物。与对照组相比,PanIN和PDAC中几种代谢物的变化趋势相似。犬尿氨酸和蛋氨酸水平在PanIN中升高,但在PDAC中降低,因此可作为区分PanIN和PDAC的生物标志物。我们的结果表明,基于NMR的技术结合多变量统计分析可以区分PanIN、PDAC和正常组织之间的代谢差异,因此为PDAC的生理病理代谢研究和早期诊断提供了一种有前景的方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b525/4968602/3c40c7f60393/CAS-107-836-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b525/4968602/4dc14d2ea6f0/CAS-107-836-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b525/4968602/b27857f0394c/CAS-107-836-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b525/4968602/dbe8407cfe39/CAS-107-836-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b525/4968602/256665f4f53f/CAS-107-836-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b525/4968602/3c40c7f60393/CAS-107-836-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b525/4968602/4dc14d2ea6f0/CAS-107-836-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b525/4968602/b27857f0394c/CAS-107-836-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b525/4968602/dbe8407cfe39/CAS-107-836-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b525/4968602/256665f4f53f/CAS-107-836-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b525/4968602/3c40c7f60393/CAS-107-836-g005.jpg

相似文献

1
Metabonomic changes from pancreatic intraepithelial neoplasia to pancreatic ductal adenocarcinoma in tissues from rats.大鼠组织中从胰腺上皮内瘤变到胰腺导管腺癌的代谢组学变化。
Cancer Sci. 2016 Jun;107(6):836-45. doi: 10.1111/cas.12939. Epub 2016 May 17.
2
Metabonomic alterations from pancreatic intraepithelial neoplasia to pancreatic ductal adenocarcinoma facilitate the identification of biomarkers in serum for early diagnosis of pancreatic cancer.从胰腺上皮内瘤变到胰腺导管腺癌的代谢组学改变有助于识别血清中的生物标志物,用于胰腺癌的早期诊断。
Mol Biosyst. 2016 Aug 16;12(9):2883-92. doi: 10.1039/c6mb00381h.
3
Non-invasively predicting differentiation of pancreatic cancer through comparative serum metabonomic profiling.通过比较血清代谢组学分析无创预测胰腺癌的分化。
BMC Cancer. 2017 Nov 2;17(1):708. doi: 10.1186/s12885-017-3703-9.
4
Expression of kallikrein-related peptidase 7 predicts poor prognosis in patients with unresectable pancreatic ductal adenocarcinoma.激肽释放酶相关肽酶 7 的表达可预测不可切除的胰腺导管腺癌患者的预后不良。
Cancer Epidemiol Biomarkers Prev. 2012 Jul;21(7):1135-42. doi: 10.1158/1055-9965.EPI-11-1079. Epub 2012 May 9.
5
Pancreatic preneoplastic lesions plasma signatures and biomarkers based on proteome profiling of mouse models.基于小鼠模型蛋白质组分析的胰腺肿瘤前病变血浆特征及生物标志物
Br J Cancer. 2015 Dec 1;113(11):1590-8. doi: 10.1038/bjc.2015.370. Epub 2015 Oct 29.
6
Understanding metabolomic characteristics of pancreatic ductal adenocarcinoma by HR-MAS NMR detection of pancreatic tissues.通过胰腺组织的高分辨率魔角旋转核磁共振检测来理解胰腺导管腺癌的代谢组学特征。
J Pharm Biomed Anal. 2020 Oct 25;190:113546. doi: 10.1016/j.jpba.2020.113546. Epub 2020 Aug 15.
7
Distinct serum metabolomics profiles associated with malignant progression in the KrasG12D mouse model of pancreatic ductal adenocarcinoma.在胰腺导管腺癌的KrasG12D小鼠模型中,与恶性进展相关的独特血清代谢组学特征。
BMC Genomics. 2015;16 Suppl 1(Suppl 1):S1. doi: 10.1186/1471-2164-16-S1-S1. Epub 2015 Jan 15.
8
Overexpression of fibroblast growth factor receptor 4 in high-grade pancreatic intraepithelial neoplasia and pancreatic ductal adenocarcinoma.纤维母细胞生长因子受体 4 在高级别胰腺上皮内瘤变和胰腺导管腺癌中的过表达。
Int J Oncol. 2011 Jan;38(1):133-43.
9
Bioinformatics analyses of infiltrating immune cell participation on pancreatic ductal adenocarcinoma progression and in vivo experiment of the therapeutic effect of Shuangshen granules.双参颗粒对胰腺导管腺癌进展中浸润免疫细胞的参与的生物信息学分析及体内疗效实验。
J Ethnopharmacol. 2024 Mar 25;322:117590. doi: 10.1016/j.jep.2023.117590. Epub 2023 Dec 17.
10
Reg proteins promote acinar-to-ductal metaplasia and act as novel diagnostic and prognostic markers in pancreatic ductal adenocarcinoma.Reg蛋白促进腺泡-导管化生,并作为胰腺导管腺癌新的诊断和预后标志物。
Oncotarget. 2016 Nov 22;7(47):77838-77853. doi: 10.18632/oncotarget.12834.

引用本文的文献

1
Identification and analysis of pancreatic intraepithelial neoplasia: opportunities and challenges.胰腺上皮内瘤变的识别与分析:机遇与挑战
Front Endocrinol (Lausanne). 2025 Jan 7;15:1401829. doi: 10.3389/fendo.2024.1401829. eCollection 2024.
2
Metabolomics unveils the mechanism of Bufei Huayu decoction in combination with cisplatin against non-small cell lung cancer (NSCLC).代谢组学揭示补肺化瘀汤联合顺铂抗非小细胞肺癌(NSCLC)的机制。
Heliyon. 2023 Aug 17;9(8):e19155. doi: 10.1016/j.heliyon.2023.e19155. eCollection 2023 Aug.
3
Metabolic profiling of induced acute pancreatitis and pancreatic cancer progression in a mutant Kras mouse model.

本文引用的文献

1
Magnetic Resonance Spectroscopy: Novel Non-invasive Technique for Diagnosing Brain Tumors.磁共振波谱分析:诊断脑肿瘤的新型非侵入性技术。
J Coll Physicians Surg Pak. 2015 Dec;25(12):863-6.
2
Presence of pancreatic intraepithelial neoplasia-3 in a background of chronic pancreatitis in pancreatic cancer patients.胰腺癌患者慢性胰腺炎背景下胰腺上皮内瘤变-3的存在情况
Cancer Sci. 2015 Oct;106(10):1408-13. doi: 10.1111/cas.12744. Epub 2015 Sep 4.
3
HR-MAS MRS of the pancreas reveals reduced lipid and elevated lactate and taurine associated with early pancreatic cancer.
突变型Kras小鼠模型中诱导性急性胰腺炎和胰腺癌进展的代谢谱分析
Front Mol Biosci. 2022 Aug 25;9:937865. doi: 10.3389/fmolb.2022.937865. eCollection 2022.
4
Metabolic Regulation of Hepatitis B Virus Infection in HBV-Transgenic Mice.乙肝病毒转基因小鼠中乙肝病毒感染的代谢调控
Metabolites. 2022 Mar 25;12(4):287. doi: 10.3390/metabo12040287.
5
Current State of "Omics" Biomarkers in Pancreatic Cancer.胰腺癌中“组学”生物标志物的现状
J Pers Med. 2021 Feb 14;11(2):127. doi: 10.3390/jpm11020127.
6
Associations between metabolites and pancreatic cancer risk in a large prospective epidemiological study.在一项大型前瞻性流行病学研究中,代谢物与胰腺癌风险之间的关联。
Gut. 2020 Nov;69(11):2008-2015. doi: 10.1136/gutjnl-2019-319811. Epub 2020 Feb 14.
7
Circulating biomarkers for early diagnosis of pancreatic cancer: facts and hopes.用于胰腺癌早期诊断的循环生物标志物:现状与展望。
Am J Cancer Res. 2018 Mar 1;8(3):332-353. eCollection 2018.
8
Identification and functional analyses of differentially expressed metabolites in early stage endometrial carcinoma.早期子宫内膜癌中差异表达代谢物的鉴定与功能分析
Cancer Sci. 2018 Apr;109(4):1032-1043. doi: 10.1111/cas.13532. Epub 2018 Mar 25.
9
Identification and causes of metabonomic difference between orthotopic and subcutaneous xenograft of pancreatic cancer.胰腺癌原位移植瘤与皮下移植瘤代谢组学差异的鉴定及原因
Oncotarget. 2017 May 22;8(37):61264-61281. doi: 10.18632/oncotarget.18057. eCollection 2017 Sep 22.
10
Recent Advances in NMR-Based Metabolomics.基于核磁共振的代谢组学的最新进展
Anal Chem. 2017 Jan 3;89(1):490-510. doi: 10.1021/acs.analchem.6b04420. Epub 2016 Dec 2.
胰腺的高分辨率魔角旋转磁共振波谱分析显示,早期胰腺癌患者存在脂质减少、乳酸和牛磺酸升高的情况。
NMR Biomed. 2014 Nov;27(11):1361-70. doi: 10.1002/nbm.3198. Epub 2014 Sep 9.
4
Mechanism of taurine-induced apoptosis in human colon cancer cells.牛磺酸诱导人结肠癌细胞凋亡的机制。
Acta Biochim Biophys Sin (Shanghai). 2014 Apr;46(4):261-72. doi: 10.1093/abbs/gmu004. Epub 2014 Mar 7.
5
Targeting of NAD metabolism in pancreatic cancer cells: potential novel therapy for pancreatic tumors.靶向胰腺癌细胞中的 NAD 代谢:胰腺肿瘤的潜在新疗法。
Clin Cancer Res. 2014 Jan 1;20(1):120-30. doi: 10.1158/1078-0432.CCR-13-0150. Epub 2013 Sep 11.
6
Metabonomic studies of pancreatic cancer response to radiotherapy in a mouse xenograft model using magnetic resonance spectroscopy and principal components analysis.基于磁共振波谱和主成分分析的胰腺癌细胞对放射治疗反应的代谢组学研究
World J Gastroenterol. 2013 Jul 14;19(26):4200-8. doi: 10.3748/wjg.v19.i26.4200.
7
Nicotinamide prohibits proliferation and enhances chemosensitivity of pancreatic cancer cells through deregulating SIRT1 and Ras/Akt pathways.烟酰胺通过调节 SIRT1 和 Ras/Akt 通路来抑制胰腺癌细胞的增殖并增强其化疗敏感性。
Pancreatology. 2013 Mar-Apr;13(2):140-6. doi: 10.1016/j.pan.2013.01.001. Epub 2013 Jan 9.
8
Differences in transcript levels of ABC transporters between pancreatic adenocarcinoma and nonneoplastic tissues.胰腺腺癌与非肿瘤组织中 ABC 转运蛋白的转录水平差异。
Pancreas. 2013 May;42(4):707-16. doi: 10.1097/MPA.0b013e318279b861.
9
Cancer metabolism: key players in metabolic reprogramming.癌症代谢:代谢重编程中的关键参与者。
Cancer Sci. 2013 Mar;104(3):275-81. doi: 10.1111/cas.12085. Epub 2013 Jan 31.
10
Prognostic significance of L-type amino-acid transporter 1 expression in surgically resected pancreatic cancer.L 型氨基酸转运蛋白 1 表达在胰腺癌手术切除中的预后意义。
Br J Cancer. 2012 Aug 7;107(4):632-8. doi: 10.1038/bjc.2012.310. Epub 2012 Jul 17.